Your browser is no longer supported. Please, upgrade your browser.
PRGO [NYSE]
Perrigo Company plc
IndexS&P 500 P/E- EPS (ttm)-1.96 Insider Own0.20% Shs Outstand133.20M Perf Week1.40%
Market Cap6.53B Forward P/E16.69 EPS next Y2.86 Insider Trans2.76% Shs Float131.95M Perf Month4.31%
Income-266.20M PEG- EPS next Q0.62 Inst Own85.80% Short Float5.06% Perf Quarter16.33%
Sales4.73B P/S1.38 EPS this Y-211.60% Inst Trans1.33% Short Ratio6.28 Perf Half Y-1.55%
Book/sh41.73 P/B1.14 EPS next Y10.34% ROA-2.00% Target Price54.13 Perf Year-6.81%
Cash/sh3.46 P/C13.78 EPS next 5Y10.00% ROE-4.00% 52W Range38.20 - 58.83 Perf YTD6.73%
Dividend0.96 P/FCF22.42 EPS past 5Y-43.60% ROI0.90% 52W High-18.87% Beta1.18
Dividend %2.01% Quick Ratio2.30 Sales past 5Y14.00% Gross Margin35.90% 52W Low24.95% ATR1.16
Employees11500 Current Ratio3.10 Sales Q/Q-6.80% Oper. Margin0.00% RSI (14)62.28 Volatility2.47% 2.25%
OptionableYes Debt/Eq0.64 EPS Q/Q-95.00% Profit Margin-4.90% Rel Volume1.62 Prev Close47.73
ShortableYes LT Debt/Eq0.63 EarningsMay 11 BMO Payout- Avg Volume1.06M Price47.73
Recom2.70 SMA202.93% SMA509.24% SMA2006.20% Volume350,582 Change0.00%
Apr-07-21Resumed RBC Capital Mkts Sector Perform $51
Jan-06-21Downgrade RBC Capital Mkts Outperform → Sector Perform $59 → $49
Apr-17-20Downgrade Argus Buy → Hold
Mar-24-20Upgrade JP Morgan Neutral → Overweight $57
Mar-20-20Upgrade SVB Leerink Mkt Perform → Outperform $54 → $52
Mar-18-20Upgrade RBC Capital Mkts Sector Perform → Outperform $58
Oct-11-19Upgrade Argus Hold → Buy
Mar-20-19Initiated SunTrust Hold
Nov-13-18Downgrade Berenberg Buy → Hold
Aug-10-18Reiterated Stifel Hold $92 → $87
Jul-30-18Downgrade Argus Buy → Hold
Jul-12-18Downgrade Goldman Neutral → Sell
Jan-03-18Initiated Leerink Partners Mkt Perform $90
Dec-08-17Upgrade Argus Hold → Buy
Nov-10-17Upgrade RBC Capital Mkts Underperform → Sector Perform $64 → $86
Oct-05-17Reiterated UBS Buy $84 → $98
Sep-07-17Initiated Oppenheimer Outperform $88
Aug-11-17Upgrade Goldman Sell → Neutral
Aug-11-17Reiterated RBC Capital Mkts Underperform $60 → $64
Jun-16-17Initiated Cantor Fitzgerald Overweight $85
Jun-10-21 01:15PM  
11:30AM  
Jun-03-21 05:58AM  
May-21-21 08:30AM  
May-19-21 08:15AM  
May-18-21 08:30AM  
May-11-21 01:30PM  
11:30AM  
09:11AM  
08:05AM  
06:47AM  
06:30AM  
05:45AM  
Apr-27-21 04:15PM  
Apr-26-21 07:20AM  
Apr-25-21 09:43AM  
Apr-23-21 09:43AM  
Apr-22-21 12:33PM  
Apr-19-21 10:35AM  
10:23AM  
Apr-14-21 03:54PM  
Mar-28-21 11:42AM  
Mar-23-21 11:10AM  
10:55AM  
Mar-10-21 10:14AM  
Mar-04-21 02:34AM  
Mar-01-21 01:00PM  
12:45PM  
10:33AM  
08:25AM  
08:08AM  
07:46AM  
07:27AM  
07:18AM  
07:05AM  
06:30AM  
04:44AM  
Feb-26-21 10:03AM  
Feb-23-21 12:12PM  
Feb-16-21 08:09AM  
Feb-03-21 08:21AM  
Jan-26-21 10:23AM  
Jan-11-21 08:00AM  
06:50AM  
Jan-10-21 10:43AM  
Dec-17-20 08:03AM  
Dec-10-20 09:40AM  
Dec-06-20 08:10AM  
Dec-04-20 11:31AM  
Nov-17-20 08:15AM  
Nov-12-20 07:05AM  
07:02AM  
Nov-09-20 01:02PM  
Nov-05-20 03:48PM  
09:37AM  
06:14AM  
Nov-04-20 06:35PM  
02:30PM  
05:18AM  
Nov-02-20 05:10PM  
09:46AM  
Oct-29-20 04:15PM  
12:40PM  
Oct-28-20 12:32PM  
Oct-22-20 10:37AM  
Oct-21-20 12:05PM  
Oct-15-20 09:20AM  
Oct-14-20 08:15AM  
Oct-06-20 01:34PM  
Sep-17-20 07:41AM  
07:29AM  
Sep-15-20 01:11PM  
Sep-14-20 03:48PM  
03:17PM  
Sep-08-20 10:29AM  
09:30AM  
Sep-04-20 11:31AM  
Sep-03-20 07:05AM  
Aug-25-20 09:52AM  
Aug-22-20 09:27AM  
Aug-11-20 09:29AM  
Aug-05-20 12:37PM  
08:25AM  
07:54AM  
07:00AM  
Aug-04-20 12:02PM  
Aug-02-20 10:15AM  
Jul-31-20 11:30AM  
Jul-29-20 02:00PM  
12:33PM  
Jul-21-20 01:21PM  
Jul-15-20 08:32AM  
Jul-12-20 08:15PM  
Jun-29-20 07:00AM  
Jun-21-20 03:32PM  
Jun-19-20 02:03PM  
08:05AM  
Jun-18-20 06:56PM  
Jun-17-20 01:38PM  
11:18AM  
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, and Dr. Fresh. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations in the United States, as well as pharmaceutical and diagnostic products in Israel. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Alford Bradley ADirectorMay 07Option Exercise42.965,804249,34013,764May 11 03:06 PM
Mann Erica LDirectorMay 07Option Exercise42.965,804249,3408,709May 11 02:57 PM
Samuels Theodore R. IIDirectorMay 07Option Exercise42.965,804249,34020,094May 11 02:58 PM
Parker Geoffrey M.DirectorMay 07Option Exercise42.965,804249,34014,245May 11 02:56 PM
KINDLER JEFFREY BDirectorMay 07Option Exercise42.965,804249,34013,761May 11 02:57 PM
Karaboutis AdrianaDirectorMay 07Option Exercise42.965,804249,34013,233May 11 02:55 PM
CLASSON ROLF ADirectorMay 07Option Exercise42.967,255311,67518,125May 11 02:56 PM
O'Connor DonalDirectorMay 07Option Exercise42.965,804249,34016,241May 11 02:56 PM
SILCOCK RAYMONDEVP, Chief Financial OfficerApr 05Option Exercise40.393,964160,10610,196Apr 07 11:46 AM
Parker Geoffrey M.DirectorMar 17Buy41.292,500103,2182,650Mar 18 02:45 PM
Janish Ronald CraigEVP, Gbl Ops & SC & CTOMar 10Sale41.232,662109,76611,731Mar 11 03:57 PM
Willis RobertEVP & CHROMar 08Option Exercise41.8269729,1493,934Mar 09 09:17 PM
SILCOCK RAYMONDEVP, Chief Financial OfficerMar 05Option Exercise41.043,629148,9346,232Mar 09 09:19 PM
Kochan SharonEVP & President RxMar 05Option Exercise41.044,057166,49938,748Mar 09 09:19 PM
KESSLER MURRAY SCEOMar 05Option Exercise41.0430,4461,249,50449,164Mar 09 09:19 PM
Dillard James E IIIEVP, Chief Scientific OfficerMar 05Option Exercise41.044,322177,37511,173Mar 09 09:17 PM
Farrington ThomasEVP and CIOMar 05Option Exercise41.042,730112,03918,468Mar 09 09:18 PM
Sorota Richard SEVP & President CSCAMar 05Option Exercise41.042,540104,24210,053Mar 09 09:18 PM
Janish Ronald CraigEVP, Gbl Ops & SC & CTOMar 05Option Exercise41.043,339137,03314,835Mar 09 09:16 PM
Quinn GrainneEVP, Chief Medical OfficerMar 05Option Exercise41.042,27993,5307,299Mar 09 09:17 PM
Willis RobertEVP & CHROMar 05Option Exercise41.042,08385,4864,788Mar 09 09:17 PM
Andersen SvendEVP & President CHCIMar 05Option Exercise41.045,500225,72019,161Mar 09 09:15 PM
KINGMA TODD WExecutive VP, General CounselMar 05Option Exercise41.045,500225,72049,523Mar 09 09:16 PM
Dillard James E IIIEVP, Chief Scientific OfficerFeb 05Option Exercise0.004,29708,913Feb 08 07:27 AM
Sorota Richard SEVP & President CSCAJan 06Buy43.487,513326,6657,513Jan 07 12:31 PM
CLASSON ROLF ADirectorNov 09Buy46.752,13799,89810,870Nov 10 02:18 PM
Samuels Theodore R. IIDirectorNov 09Buy46.914,500211,11218,118Nov 10 11:48 AM
Willis RobertEVP & CHROAug 14Option Exercise53.4058131,0252,358Aug 17 12:32 PM
Andersen SvendEVP & President CHCIAug 11Buy53.012,828149,91010,028Aug 11 10:58 AM
Janish Ronald CraigEVP, Global Op. & Supply ChainJun 29Option Exercise54.5682745,1219,429Jul 01 02:00 PM
Farrington ThomasEVP and CIOJun 29Option Exercise54.561,39876,27514,803Jul 01 01:58 PM
Kochan SharonEVP, GM InternationalJun 29Option Exercise54.562,285124,67031,307Jul 01 01:59 PM
Quinn GrainneEVP, Chief Medical OfficerJun 29Option Exercise54.5626214,2954,796Jul 01 01:59 PM
Willis RobertEVP & CHROJun 29Option Exercise54.5627014,7311,918Jul 01 01:58 PM
Needham JeffreyEVP, President CHC AmericasJun 29Option Exercise54.562,322126,68832,149Jul 01 01:57 PM
KINGMA TODD WExecutive VP, General CounselJun 29Option Exercise54.562,987162,97140,698Jul 01 01:56 PM